Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Mitchell

Showing results (21-30 of 249) with videos related to

Pageof 25
Sort By:
Nature Biotechnology|July 31, 2002
Biotech stocks struggle as financial markets tumblePeter Mitchell
Nature Biotechnology|April 1, 2003
UK bidding war amidst merger maniaPeter Mitchell
Nature Biotechnology|May 2, 2003
Europe sees sharp decline in GMO researchPeter Mitchell
Nature Biotechnology|August 3, 2004
IPO plans sour on both sides of the pondPeter Mitchell
Nature Biotechnology|March 10, 2010
Ark's gene therapy stumbles at the finish linePeter Mitchell
Nature Biotechnology|August 6, 2005
Next-generation monoclonals less profitable than trailblazers?Peter Mitchell
Nature Biotechnology|July 10, 2009
Governments fiddle while biotech burnsPeter Mitchell
Nature Ecology & Evolution|September 19, 2024
Population continuity and change in Africa's far southPeter Mitchell
Nature Biotechnology|March 1, 2003
In the pursuit of industrial proteomicsPeter Mitchell
Nature Medicine|March 4, 2003
UK to regulate 'serious' genetic testsPeter Mitchell
Pageof 25

Showing results (21-30 of 249) with videos related to

Sort By:
Pageof 25
Nature Biotechnology|July 31, 2002
Biotech stocks struggle as financial markets tumblePeter Mitchell
Nature Biotechnology|April 1, 2003
UK bidding war amidst merger maniaPeter Mitchell
Nature Biotechnology|May 2, 2003
Europe sees sharp decline in GMO researchPeter Mitchell
Nature Biotechnology|August 3, 2004
IPO plans sour on both sides of the pondPeter Mitchell
Nature Biotechnology|March 10, 2010
Ark's gene therapy stumbles at the finish linePeter Mitchell
Nature Biotechnology|August 6, 2005
Next-generation monoclonals less profitable than trailblazers?Peter Mitchell
Nature Biotechnology|July 10, 2009
Governments fiddle while biotech burnsPeter Mitchell
Nature Ecology & Evolution|September 19, 2024
Population continuity and change in Africa's far southPeter Mitchell
Nature Biotechnology|March 1, 2003
In the pursuit of industrial proteomicsPeter Mitchell
Nature Medicine|March 4, 2003
UK to regulate 'serious' genetic testsPeter Mitchell
Pageof 25